Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,106 public trials 2,040 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL)

NCT03571308

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Southampton University Hospitals NHS Tust Southampton, Hampshire, United Kingdom
  • St James's University Hospital Leeds, United Kingdom
  • University College London Hospitals London, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
View Trial Details
Completed

Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma

NCT03603847

Conditions
Anaplastic Large Cell Lymphoma, ALK-Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • CHU Amiens - Hôpital Sud Amiens, France
  • CHU d'Estaing Clermont-Ferrand, France
  • APHP - Hopital Henri Mondor Créteil, France
  • CHU Grenoble Grenoble, France
View all 15 locations
View Trial Details
Completed

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

NCT01336933

Conditions
Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • Mayo Clinic, Arizona Scottsdale, Arizona, United States
  • Stanford University Stanford, California, United States
  • Emory University School Of Medicine Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

NCT00352027

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
  • Maine Children's Medical Center Portland, Maine, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)

NCT02312258

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Robert A Moss MD FACP Inc Fountain Valley, California, United States
  • UCLA Medical Hematology and Oncology Los Angeles, California, United States
  • North County Oncology Medical Clinic Inc Oceanside, California, United States
  • Ventura County Hematology Oncology Specialists Oxnard, California, United States
View all 275 locations
View Trial Details

Related conditions